Collector
Swedish rare disease patients endure longer wait for new medicines [Advocacy Lab] | Collector
Swedish rare disease patients endure longer wait for new medicines [Advocacy Lab]
EURACTIV

Swedish rare disease patients endure longer wait for new medicines [Advocacy Lab]

It takes more than 21 months for a new orphan drug to reach Sweden, the average time to availability has risen by 153 days

Go to News Site